CA
NZ
UK
AU
IND
US
…
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -90.81M | -123.88M | -148.68M | -17.71M | -13.49M |
| Net income | -92.19M | -126.00M | -151.40M | -19.75M | -38.38M |
| Selling general administrative | 554.33M | 532.52M | 144.66M | 79.97M | 69.35M |
| Selling and marketing expenses | - | - | 385.74M | 228.81M | 221.32M |
| Gross profit | 551.71M | 545.88M | 486.27M | 337.17M | 349.56M |
| Reconciled depreciation | 83.25M | 76.00M | 60.60M | 32.08M | 33.09M |
| Ebit | -73.32M | -94.24M | -140.05M | -20.67M | -6.23M |
| Ebitda | -22.35M | -34.18M | -79.49M | -23.82M | 26.86M |
| Depreciation and amortization | 50.97M | 60.06M | 60.56M | -3.15M | 33.09M |
| Non operating income net other | - | - | - | -2.75M | -4.29M |
| Operating income | -68.47M | -84.62M | -139.11M | -20.67M | -6.23M |
| Other operating expenses | 890.78M | 884.11M | 885.75M | 481.38M | 455.21M |
| Interest expense | 17.49M | 29.63M | 8.63M | 1.29M | 1.84M |
| Tax provision | 1.38M | 2.12M | 2.72M | 2.04M | 24.88M |
| Net interest income | -17.49M | -29.63M | -8.63M | -1.29M | -1.84M |
| Income tax expense | 1.38M | 2.12M | 2.72M | 2.04M | 24.88M |
| Total revenue | 822.31M | 799.49M | 746.64M | 460.71M | 464.48M |
| Total operating expenses | 620.18M | 630.50M | 625.38M | 357.84M | 340.29M |
| Cost of revenue | 270.61M | 253.61M | 260.37M | 123.54M | 114.91M |
| Total other income expense net | -22.34M | -39.26M | -9.57M | 2.97M | -7.26M |
| Net income from continuing ops | -92.19M | -126.00M | -151.40M | -19.75M | -38.38M |
| Net income applicable to common shares | - | - | - | -19.75M | -38.38M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 850.65M | 893.29M | 925.32M | 458.63M | 476.62M |
| Intangible assets | 72.77M | 98.80M | 117.49M | 47.39M | 52.67M |
| Other current assets | 164.91M | 25.88M | 32.42M | 22.28M | 20.14M |
| Total liab | 400.61M | 390.17M | 326.58M | 121.77M | 139.69M |
| Total stockholder equity | 450.04M | 503.12M | 598.73M | 336.86M | 336.93M |
| Deferred long term liab | - | - | - | 0.70M | 1.00M |
| Other current liab | 108.11M | 106.63M | 101.43M | 55.37M | 76.78M |
| Common stock | 3.98M | 3.85M | 3.72M | 2.02M | 1.98M |
| Capital stock | 3.98M | 3.85M | 3.72M | 2.02M | 1.98M |
| Retained earnings | -368.33M | -276.14M | -150.14M | 1.25M | 21.00M |
| Other liab | - | - | - | 13.53M | 13.97M |
| Good will | 194.93M | 194.93M | 194.93M | 71.32M | 71.32M |
| Other assets | - | 398.54M | - | 12.83M | 23.87M |
| Cash | 82.03M | 83.24M | 37.76M | 50.70M | 87.85M |
| Total current liabilities | 170.48M | 168.63M | 165.22M | 83.62M | 105.83M |
| Net debt | 147.24M | 96.39M | 96.44M | -30.81M | -65.37M |
| Short term debt | 3.98M | 4.78M | 5.43M | 0.65M | 2.59M |
| Short long term debt | - | - | 1.25M | - | - |
| Short long term debt total | 229.26M | 179.63M | 134.20M | 19.89M | 22.48M |
| Other stockholder equity | 813.77M | 779.72M | 746.45M | 334.97M | 313.95M |
| Property plant equipment | - | - | - | 58.23M | 59.25M |
| Total current assets | 416.85M | 433.29M | 420.44M | 255.99M | 269.52M |
| Net tangible assets | - | - | - | 218.16M | 212.95M |
| Net receivables | 135.75M | 134.71M | 128.10M | 82.86M | 78.56M |
| Long term debt | 157.39M | 157.01M | 93.11M | - | - |
| Inventory | 34.17M | 189.45M | 222.17M | 100.15M | 82.97M |
| Accounts payable | 58.39M | 48.80M | 58.36M | 27.60M | 26.46M |
| Accumulated other comprehensive income | 0.62M | -4.30M | -1.29M | -1.38M | - |
| Common stock total equity | - | - | - | 2.02M | 1.98M |
| Retained earnings total equity | - | - | - | 1.25M | 21.00M |
| Non currrent assets other | -77.44M | 26.47M | 11.14M | 25.70M | 22.09M |
| Non current assets total | 433.80M | 460.01M | 504.87M | 202.64M | 207.10M |
| Capital lease obligations | 21.04M | 22.61M | 22.72M | 21.53M | 24.31M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00M | -27.58M | -33.13M | -24.53M | -2.17M |
| Change to liabilities | - | - | - | 2.91M | 5.27M |
| Total cashflows from investing activities | -34.60M | -27.58M | - | -24.53M | -23.01M |
| Net borrowings | -0.76M | 54.39M | - | -0.09M | -0.95M |
| Total cash from financing activities | -0.79M | 50.71M | 65.32M | -0.08M | -3.62M |
| Change to operating activities | - | - | - | -1.86M | -13.46M |
| Net income | -92.19M | -126.00M | -151.40M | -19.75M | -38.38M |
| Change in cash | -0.62M | 47.98M | -12.94M | -37.15M | -8.97M |
| Begin period cash flow | 85.74M | 37.76M | 50.70M | 87.85M | 96.82M |
| End period cash flow | 85.11M | 85.74M | 37.76M | 50.70M | 87.85M |
| Total cash from operating activities | 33.35M | 25.79M | -45.75M | -11.54M | 18.48M |
| Issuance of capital stock | 5.93M | 6.26M | 5.13M | 4.34M | 8.82M |
| Depreciation | 83.25M | 75.96M | 53.06M | 32.08M | 33.09M |
| Other cashflows from investing activities | 0.03M | -0.10M | - | -3.17M | -3.06M |
| Dividends paid | - | - | - | 1.73M | 2.56M |
| Change to inventory | -10.75M | -5.55M | -58.05M | -18.13M | 0.62M |
| Change to account receivables | -1.58M | -9.53M | -10.41M | -6.74M | -7.05M |
| Sale purchase of stock | - | - | -4.40M | -1.73M | -2.56M |
| Other cashflows from financing activities | -5.95M | -9.94M | 128.14M | 1.64M | -6.80M |
| Change to netincome | - | - | - | 5.68M | 49.60M |
| Capital expenditures | 34.63M | 34.88M | 62.05M | 23.16M | 19.59M |
| Change receivables | - | - | - | -6.74M | -7.05M |
| Cash flows other operating | - | - | - | -4.53M | -21.18M |
| Cash and cash equivalents changes | - | - | - | -36.15M | -8.16M |
| Change in working capital | -21.50M | -19.25M | -53.96M | -29.23M | -18.10M |
| Stock based compensation | 28.69M | 32.45M | 35.71M | 18.44M | 15.43M |
| Other non cash items | 34.87M | 60.74M | 70.26M | -13.39M | 1.95M |
| Free cash flow | -1.28M | -9.09M | -107.80M | -34.70M | -1.12M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical Inc |
-0.05 0.70% |
7.13 | - | 500.00 | 0.44 | 0.86 | 0.60 | 26.44 |
| ABT Abbott Laboratories |
-0.71 0.65% |
108.58 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
0.28 0.28% |
101.89 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-2.16 0.68% |
316.63 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
- -% |
47.31 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
| Name | Title | Year Born |
|---|---|---|
| Mr. Jon C. Serbousek | Pres, CEO & Director | 1961 |
| Mr. Douglas C. Rice | CFO & Chief Accounting Officer | 1966 |
| Ms. Kimberley A. Elting | Chief Legal & Devel. Officer and Pres of the Global Orthopedics | 1965 |
| Mr. Kevin J. Kenny | Pres of Global Spine Bus. | 1965 |
| Mr. Roberto Donadello | Sr. VP of Global Operations | NA |
| Dr. James T. Ryaby B.A., Chemistry, Ph.D. | Chief Scientific Officer | 1959 |
| Mr. Dan E. Yarbrough | VP of Investor Relations | NA |
| Ms. Suzanne Armstrong | Sr. VP of HR | NA |
| Mr. Ehab M. Esmail | Sr. VP of Quality, Regulatory & Clinical Affairs | 1972 |
| Mr. Mark Quick | Sr. Director of Bus. Devel. & Investor Relations | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.40%
Communication Services
-0.45%
Consumer Cyclical
-0.55%
Consumer Defensive
-0.01%
Energy
-0.01%
Financial Services
-0.40%
Financials
-0.15%
Healthcare
-1.15%
Industrials
-0.46%
Real Estate
-0.29%
Technology
-1.22%
Utilities
-0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
+0.55%
Please wait processing your request...